Navigation Links
Kinovate Life Sciences Launches Nittophase?High Performance Solid Support For Oligonucleatide Synthesis

Kinovate Life Sciences, Inc, a provider of tools for oligonucleotide synthesis and gene delivery, announced today that it will officially launch its new NittoPhase?solid support for oligonucleotide synthesis at the TIDES meeting commencing in Boston on May 1st. The joint development of this solid phase support product was announced on November 8th, 2004 by Kinovate’s sole shareholder, Nitto Denko Corporation (Osaka, Japan), a leading multi-national polymer synthesis company and Isis Pharmaceuticals, Inc. (NASDAQ: ISIS), a leader in RNA-based drug discovery and development.

Through utilization of the unparalleled polymer synthesis and R&D capabilities of Nitto Denko Corporation, Isis?outstanding oligonucleotide synthesis and drug development expertise and the worldwide marketing and customer support operations of Kinovate Life Sciences, this new product promises to deliver significantly improved technical and economic outcomes for all segments of the oligonucleotide industry.

Solid support is the base structure used in the synthesis of oligonucleotides, including diagnostic probes and primers, antisense including RNAi, microRNA, DNA-based and aptamer drugs and represents a substantial portion of the cost to manufacture these oligonucleotides.

NittoPhase?has been rigorously tested at both small and large scales, and has been observed to exhibit superior characteristics and performance when compared to other solid supports currently on the market. NittoPhase?has great potential to decrease manufacturing costs due to it’s significantly lower unit cost, as well as potentially higher yield and full length purity, reducing cost-of-goods. NittoPhase?will be commercially available in two grades; NittoPhaseTOS?for high loading applications, and NittoPhaseROS?for lower loading applications. In this way, NittoPhase?offers a solution for the entire spectrum of oligonucleotide synthesis applications.

“Kinovate Life Sciences aims to be a robust p
'"/>

Source:PRWeb


Page: 1 2

Related biology news :

1. Affymetrix Licenses Microfluidics Technology From Caliper Life Sciences
2. TrueBlue Archive Will Store Raw Life Sciences Data for Proteomics and Drug Testing
3. Sangamo BioSciences demonstrates its ZFP treatment protects cells from HIV infection
4. Affymetrix Launches New Globin-Reduction Kits and Protocol Developed with PreAnalytiX
5. IMF Launches World’s First DNA Database for Myeloma Patients
6. Invitrogen Launches i-Path -- A Unique Systems Biology Platform at BIO 2005
7. UCLA Study Shows One-Third of Drug Ads in Medical Journals Do Not Contain References Supporting Medical Claims

Post Your Comments:
(Date:11/4/2009)...wire/ -- Glencoe Software, Inc., the commercial ar...ium ( http://openmicroscopy.org ), is proud to a...y of Cell Biology,s exciting new project titled "T...ded a $2.5M stimulus grant through the National In...gram, as part of the American Reinvestment and Rec...
(Date:11/3/2009)...ultimate loner of the ocean, cruising thousands of...rs has discovered that the sharks have maintained ...ens of thousands of years the white sharks in the ...es into a population genetically distinct from sha...a large, highly mobile species," said Salvador Jor...
(Date:11/3/2009)...women are as much as 28 percent less likely to bec...rding to research that earned a Michigan State Uni...gs by Barbara Luke, a researcher in the MSU Colleg...necology and Reproductive Biology, focused on data...e technology. , Luke,s findings, which also can ...
Breaking Biology News(10 mins):Glencoe Software to Support the ASCB 'Stimulus Grant' to Build Virtual Image Library of the Cell 2Tags reveal white sharks have neighborhoods in the north Pacific, say Stanford researchers 2Tags reveal white sharks have neighborhoods in the north Pacific, say Stanford researchers 3Tags reveal white sharks have neighborhoods in the north Pacific, say Stanford researchers 4MSU researcher: Obesity significantly cuts odds of successful pregnancy 2Advance in Bowel Cancer Test Research 4533 1Advance in Bowel Cancer Test Research 4533 2QIO Support Accelerates Hospital Improvement in Heart Care Researchers Find 47853 1QIO Support Accelerates Hospital Improvement in Heart Care Researchers Find 47853 2Two Ways to Tackle Tuberculosis 47849 1Two Ways to Tackle Tuberculosis 47849 2Two Ways to Tackle Tuberculosis 47849 3
...from Université Laval’s Faculty of Medicine have s...cells extracted from adult human skin. This is the...ifferentiation has been achieved from human skin, ...rthod. This breakthrough could eventually lead to ...generative illnesses such as Parkinson’s disease. ...
...from the NIOZ Royal Netherlands Institute for Sea ...mperature record for tropical central Africa over ...n with a German colleague from the University of B...thod to reconstruct the history of land temperatur.... They applied the method to a marine sediment cor...
...on,s under stress or injured, the adrenal gland re...ns to normal. But the hormone,s effects are many a...tem, helping create memories with short-term expos...for too long. Given the variety of its effects,und...oducing medications that can alter its production....
Other Biology News:Scientists produce neurons from human skin 2Microfossils unravel climate history of tropical Africa 2Scientists unravel clue in cortisol production 2
(Date:11/6/2009)...wswire-FirstCall/ -- BioSpecifics Technologies Cor...eveloping first-in-class collagenase-based product...hird quarter ended September 30, 2009. ,, "We ...ar, the FDA,s Arthritis Advisory Committee unanimo...of XIAFLEX(TM) for the treatment of Dupuytren,s di...
(Date:11/6/2009)...RNewswire-FirstCall/ -- ,, 3Q09 Corporate Hi...M) E.U. Marketing Authorization to Astellas Pharma...cial readiness activities Expanded management tea... and Director, Commercial Operations Appointed Br...ommittee chairman , Upcoming 2009 Milestone...
(Date:11/6/2009)...da for Arrowhead’s 2010 Personalized Medicin...ace on February 22-24, 2010 in Philadelphia, has b...l highlight key issues in forming partnerships and...es. , Minneapolis, MN (PR...rsquo;s 2010 Personalized Medicine Partnerships C...
(Date:11/5/2009)...Newswire/ -- DSM Pharmaceutical Products today ann...ith Galenix, Saint Jean D,Illac, France, where DSM...ing partner for Galenix commercial products on a g...e on business development opportunities co-marketi...e strength of Galenix in drug product development ...
Breaking Biology Technology:Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 6NeurogesX Reports Third Quarter 2009 Results 2NeurogesX Reports Third Quarter 2009 Results 3NeurogesX Reports Third Quarter 2009 Results 4NeurogesX Reports Third Quarter 2009 Results 5NeurogesX Reports Third Quarter 2009 Results 6NeurogesX Reports Third Quarter 2009 Results 7NeurogesX Reports Third Quarter 2009 Results 8NeurogesX Reports Third Quarter 2009 Results 9NeurogesX Reports Third Quarter 2009 Results 10Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 3DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3
...IVUS, Inc. (Nasdaq: VVUS ), a biopharmaceutica...ialization of novel therapeutic products, today re...e first quarter ended March 31, 2009. , , Firs...ssuance of Key European Patent for Qnexa - In Jan...ffice had granted a patent for Qnexa. The European...
...al Arts Alliance , , BATON ROUGE, La., May 11 Th...ort, for the second year in a row, Louisiana State...n for Students (BIOS) program with scholarships an...n Foundation Digital Arts Fellows will use video c... along to future program participants. Films from ...
..., Inc. (Pink Sheets: NNLX) is pleased to announce ... evaluate and target research and development effo... the company with a vastly expanded scope of exper... , Dr. Robert Ollar, NanoLogix cofounder and autho... the NanoLogix Board of Directors to assume the po...
Other Biology Technology:VIVUS Reports First Quarter 2009 Financial Results and Highlights 2VIVUS Reports First Quarter 2009 Financial Results and Highlights 3VIVUS Reports First Quarter 2009 Financial Results and Highlights 4VIVUS Reports First Quarter 2009 Financial Results and Highlights 5VIVUS Reports First Quarter 2009 Financial Results and Highlights 6VIVUS Reports First Quarter 2009 Financial Results and Highlights 7Pearson Foundation Supports Incoming LSU Biology Students With 21st Century Learning Tools 2Pearson Foundation Supports Incoming LSU Biology Students With 21st Century Learning Tools 3A Global View: NanoLogix Creates Science Advisory Board 2A Global View: NanoLogix Creates Science Advisory Board 3A Global View: NanoLogix Creates Science Advisory Board 4A Global View: NanoLogix Creates Science Advisory Board 5
MitoScreen (JC-1) Kit from BD Biosciences Pharmingen
Thermal Printer Paper for Monolight Luminometer 1 each from BD Biosciences Pharmingen
Custom Production Service - Quality from AbD Serotec
Vybrant Apoptosis Assay Kit #7 - Hoechst 33342/YO-PRO-1/propidium iodide - 200 assays from Molecular Probes (Invitrogen)
Biology Products: